Plasma markers of endothelial dysfunction in type 2 diabetics

European Journal of Internal Medicine

Volumn 17, Issue 1, 2006, Pages 38-42

  Moldoveanu, Elena ^a   Tanaseanu, Cristina ^b   Tanaseanu, Stefanita ^c   Kosaka, Tetsuya ^d   Manea, Gabriela ^a   Marta, Daciana S ^a   Popescu, Laurentiu M ^a  

^a VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^b Emergency Hospital Sf Pantelimon   (Romania)

^c Carol Davila School of Medicine   (Romania)

^d Alfresa Pharma Corporation   (Japan)

Author keywords

Inflammation; Lipoprotein associated phospholipase A 2; Myeloperoxidase; Paraoxonase; Type 2 diabetes

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ENZYME; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; PHOSPHOLIPASE A2;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA;

EID: 29344445876     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.09.015     Document Type: Article

References (35)

1. S.M. Grundy, I.J. Benjamin, and G.L. Burke Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 100 1999 1134 1146
2. Miles Fisher Diabetes and atherogenesis Heart 90 2004 336 340
3. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease. The Framingham study JAMA 241 1979 2035 2038
4. A.J. Garber Vascular disease and lipids in diabetes Med Clin North Am 82 4 1998 931 948
5. S.M. Haffner, S. Lehto, and T. Rönnemaa Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
6. American Diabetes, Association Management of dyslipidemia in adults with diabetes Diabetes Care 24 suppl. 1 2001 S58 S61
7. V. Schachinger, and A.M. Zeiher Prognostic implications of endothelial dysfunction: does it mean anything? Coron Artery Dis 12 6 2001 435 443
8. W.A. Hsueh, C.J. Lyon, and M.J. Quinones Insulin resistance and the endothelium Am J Med 117 2 2004 109 117
9. M. Serban, C. Tanaseanu, and T. Kosaka Significance of platelet-activating factor acetylhydrolase in patients with non-insulin- dependent (type 2) diabetes mellitus J Cell Mol Med 6 4 2002 643 647
10. L.D. Tsironis, C.S. Katsouras, and E.S. Lourida Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease Atherosclerosis 177 1 2004 193 201
11. 2 J Biochem 131 2002 285 292
12. T. Murohara, R. Scalia, and A.M. Lefer Lysophosphatidylcholine promotes P-Selectin expression in platelets and endothelial cells: possible involvement of protein kinase C activation and its inhibition by nitric oxide donors Circ Res 78 1996 780 789
13. C.J. Packard, D.S.J. O'Reilly, and M.J. Caslake The west of Scotland coronary prevention study group. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease N Engl J Med 343 2000 1148 1155
14. G.J. Blake, N. Dada, and J.C. Fox A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women J Am Coll Cardiol 38 5 2001 1302 1306
15. C. Tanaseanu, E. Moldoveanu, and T. Kosaka The significance of human platelet-activating factor acetylhydrolase in patients with chronic stable angina Eur J Med 15 2004 291 297
16. X. Fu, S.Y. Kassim, and W.C. Parks Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (Matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation J Biol Chem 278 2003 28403 28409
17. R. Zhang, M.L. Brennan, and X. Fu Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142
18. W. Jessup, and L. Kritharides Metabolism of oxidized LDL by macrophages Curr Opin Lipidol 11 5 2000 473 481
19. K. Zouaoui Boudjeltia, N. Moguilevsky, and I. Legssyer Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation Biochem Biophys Res Commun 325 2 2004 434 438
20. M.H. Shishehbor, R.J. Aviles, and M.L. Brennan Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy JAMA 289 2003 1675 1680
21. B.M. Murtagh, and H.V. Anderson Inflammation and atherosclerosis in acute coronary syndromes J Invasive Cardiol 16 7 2004 377 384
22. B. Mackness, P. Durrington, and P. McElduff Low paraoxonase activity predicts coronary events in the caerphilly prospective study Circulation 107 2003 2775 2779
23. V.G. Cabana, C.A. Reardon, and N. Feng Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response J Lipid Res 44 2003 780 792
24. Y. Hayashino, S. Nagata-Kobayashi, and T. Morimoto Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with type 2 diabetes and additional atherogenic risk factors J Gen Intern Med 19 12 2004 1181 1191
25. B. Ugur-Altun, A. Altun, E. Tatli, and A. Tugrul Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients Diabetes Res Clin Pract 67 2 2005 130 136
26. T. Kosaka, M. Yamaguchi, and Y. Soda Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity Clin Chim Acta 296 1-2 2000 151 161
27. R. Buchmann, A. Hasilik, and T.E. Van Dyke Amplified crevicular leukocyte activity in aggressive periodontal disease J Dent Res 81 2002 716 721
28. N. Ahmed Advanced glycation endproducts-role in pathology of diabetic complications Diabetes Res Clin Pract 67 1 2005 3 21
29. A. Lapolla, P. Traldi, and D. Fedele Importance of measuring products of non-enzymatic glycation of proteins Clin Biochem 38 2 2005 103 115
30. 1c within the normal range Eur Heart J 25 2004 2120 2124
31. A. Ayub, M.I. Mackness, and S. Arrol Serum paraoxonase after myocardial infarction Arterioscler Thromb Vasc Biol 19 1999 330 335
32. P.N. Durrington, B. Mackness, and M.I. Mackness Paraoxonase and atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 473 480
33. C.C. Hedrick, S.R. Thorpe, and M.X. Fu Glycation impairs high-density lipoprotein function Diabetologia 43 3 2000 312 320
34. P.B. Duell, J.F. Oram, and E.L. Bierman Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux Diabetes 40 1991 377 384
35. B. Mackness, D. Hine, and Y. Liu Paraoxonase-1 inhibits oxidised LDL-induced CP-1 production by endothelial cells Biochem Biophys Res Commun 318 3 2004 680 683